Insulet Receives FDA Clearance For Omnipod For Children Ages 2 And Up
Executive Summary
Insulet widens the launch of its Omnipod 5 automated insulin delivery system with the FDA clearance for children ages 2 and up. Previously, the system was available to people aged 6 years and older.
You may also be interested in...
Minute Insight: Insulet Launches Omnipod 5 US-Wide Following Trial Period
After six months, the Omnipod 5 has seen its limited market launch expanded to cover the entirety of the US market.
ADA 2022 Wrap Up: Iterative Progress On Glucose Control, No Big Surprises
The major players in the diabetes tech sector announced new and re-hashed old clinical data at this year’s American Diabetes Association Scientific Sessions in New Orleans.
Women’s Health Expert Panel Addresses Challenges, Opportunities In Post-Roe Era
After years of underfunding, stigmatization and lack of research, companies working on products and services that address women’s health care are gaining traction. But the sector also faces unique challenges, such as gaining approval for ads on major social media platforms.